Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Guidance and Visibility -- Ignore unavailable to you. Want to Upgrade?

To: hotlinktuna who wrote (111247)	3/18/2004 8:43:28 AM
From: Connor26	Read Replies (2) \| Respond to of 208838

7:20AM FDA panel backs temporary artificial heart - Reuters : A U.S. Food and Drug Administration panel on Wednesday backed an artificial heart to keep the sickest patients alive while they wait for a transplant. The CardioWest Total Artificial Heart by SynCardia Systems would be the first on the market if the panel's 10-1 recommendation is followed by the FDA. The agency usually agrees with the advice of its expert panels. Another company, Abiomed Inc. (ABMD) hopes to win FDA approval of its artificial heart called AbioCor by the second half of 2004. Unlike SynCardia's device, the AbioCor is completely implanted.